XENOVIEW (xenon xe-129 hyperpolarized)
Xenoview is a contrast agent used during MRI scans to assess how air moves through the lungs. It helps clinicians evaluate lung ventilation in both adults and children as young as six years old. This imaging tool provides a way to visualize the distribution of air within the respiratory system.
How XENOVIEW Works
This agent works by having the patient inhale hyperpolarized xenon Xe 129 gas, which can then be tracked by a multi-nuclear capable MRI scanner. A specific Xe 129 MRI coil directly detects the nuclei to create an image of how the gas is distributed throughout the ventilated areas of the lungs.
Details
- Status
- Prescription
- First Approved
- 2022-12-23
- Patent Cliff
- 2035
- Routes
- INHALATION
- Dosage Forms
- GAS
XENOVIEW Approval History
What XENOVIEW Treats
2 indicationsXENOVIEW is approved for 2 conditions since its original approval in 2022. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Lung ventilation evaluation (adults)
- Lung ventilation evaluation (pediatric patients 6 years and older)
XENOVIEW Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
XENOVIEW FDA Label Details
Indications & Usage
FDA Label (PDF)XENOVIEW is indicated for the treatment of Lung ventilation evaluation (adults); Lung ventilation evaluation (pediatric patients 6 years and older).
XENOVIEW Patents & Exclusivity
Patents (2 active)
Exclusivity
Pro Intelligence Preview
Deep insights for XENOVIEW
Revenue Insights
- • Quarterly revenue tracking
- • Historical trend analysis
Patent Timeline
- • Cliff: 2035
- • 2 active patents
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • Competitor tracking
- • Same target/indication analysis
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.